Skip to main content
OpenTrials
Completed

NCT Number: NCT02555202

Validation of French Version of LCADL and Dyspnea-12

The main objective of this study is to develop and to validate a French version of the London Chest Activity of Daily Living (LCADL) and the Dyspnea 12 and to determine the reliability of this version for the evaluation of the dyspnea in the Activity of Daily Living in COPD patients (stages severe and very severe).

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COPD with FEV1< 50% of predictive value

Exclusion criteria

  • FEV1> 50% of predictive value
  • Patients with an exacerbation of COPD in the previous 30 days the inclusion

Treatment and study plan

Primary outcomes

  1. the Saint-Georges questionnaire, item Activity

    Time frame: 15 days

    by comparison with item activities of the Saint-Georges questionnaire for the LCADL

  2. MMRC Dyspnea scale

    Time frame: 15 days

    by comparison with MMRC dyspnea scale for the dyspnea 12

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Validation of the French Version of the London Chest Activity of Daily Living Scale (LCADL) and the Dyspnea-12 Questionnaire

Acronym: LCADL

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Sep 21, 2015
Registry last updated
Mar 31, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.